Zstock2020
Posted - 1 day ago
$UNCY isn’t the problem here that they only have money for 1-2 quarters left? I don’t see that they raised recently?
pazzaaaaaa
Posted - 4 days ago
$UNCY Just saw the CEOs company update/presentation. He didn’t release any data but he’s very excited for the data coming out soon on their current trials. This stock is a sleeping giant and could easily hit the 4-5$ range in a day on good data.
MKRReformed
Posted - 4 days ago
$uncy massive candle 👀
ICU2025
Posted - 5 days ago
$UNCY looks like nothing came out of the speech this morning, probably means under $1 incoming.
When are results for last phase expected.
Earth4thewin
Posted - 5 days ago
$UNCY analysts are setting price targets between $3 to $9 on $UNCY . 🤷
pazzaaaaaa
Posted - 5 days ago
$UNCY Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer will present a company update at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on Thursday April 18, 2024 at 11:00 a.m. ET.
Finally found a nice floor at 1.05-1.10 right before a company update tomorrow. Lots of volume this past week. Somethings brewing…
Americanbulls
Posted - 5 days ago
$UNCY the bull pattern is confirmed & a BUY signal is issued @ www.Americanbulls.com/SignalPage.aspx?lang=en&Ticker=UNCY. Buy Level: 1.14 Target: 2.97
ICU2025
Posted - 1 week ago
$UNCY it’s very easy for firms and M Ms to manipulate these small stocks.
Until revenue is streaming in I think you trade it vs holding.
I will buy again under $1.00 and hold for run on the data results in June
reces1
Posted - 1 week ago
$UNCY Just a brutal takedown the last two weeks. Free fall.
ICU2025
Posted - 1 week ago
$RMTI $DVA will buy us sooner than later Who ends up with $ICU and $UNCY Is the big question? What a great and interesting 24 months are ahead for us.
pazzaaaaaa
Posted - 1 week ago
$UNCY CEO will present company update next. Doubt he’s gonna present bad news at a conference, very bullish
iLikeMyUsername
Posted - 1 week ago
$UNCY
TragicTwits
Posted - 1 week ago
$UNCY added some more $1.30
pazzaaaaaa
Posted - 1 week ago
$UNCY it’s so obviously being brought down by someone who wants cheaper prices. Down 15% since a 9$ price target was announced and trading at a 40million market cap while they have 50 million just in cash among other things like patents worth a lot. Interesting…
Stock_Titan
Posted - 1 week ago
$UNCY Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
https://www.stocktitan.net/news/UNCY/unicycive-therapeutics-to-present-at-the-noble-capital-markets-4i95t5wrqj36.html
reces1
Posted - 2 weeks ago
$UNCY Hmmm.
WagTwits
Posted - 2 weeks ago
$UNCY undervalued
reces1
Posted - 2 weeks ago
$UNCY Going to keep waiting on entry. Unlimited hidden shares at $1.41. Not letting it run.
pazzaaaaaa
Posted - 2 weeks ago
$UNCY insane that this stock is trading at 1.40$/50Mil market cap when they have 50Mil in cash. Very good data already and massive upside potential waiting for more data which is coming very soon with multiple buy ratings ranging from 5-12$. New buy ratings and bullish price targets coming in every month. Worried about bad data coming in? Sure but look at the risk to reward ratio. Good data will boost this to 10-12$ easily which is 6-8x from here. Bad data which isn’t very likely at this point will obviously ruing the company but I’m willing to take this risk for a 6-8x.
Walter100
Posted - 2 weeks ago
$UNCY From X:
newandimproveddonkeykong
Posted - 2 weeks ago
@Jeffkad @Elvis50 Piper Sandler has to eat too....Spectrum was doing safety trials on this drug in 2013. FDA already kicked it back once and asked for more data. There are plenty of binders out there, some generic, government is a big payer and Renazorb's angle is pill burden. Sevelamer + Tenapanor has already had a real study (multiple ones). Millions of patients have used sevelamer, tens of thousands have used tena for IBS, thousands have gone through trials with Tenapanor for hyperphos.... The FDA isn't just there to just rubber stamp trials. They actively guide healthcare and care pathways through approvals. Why move Renazorb along quickly now after more than a decade? Maybe something happens with $UNCY, but my bet is that spend the most recent 50 million they raised like they spent the last 50 million they raised and maybe they get a PDUFA date. Maybe they get an approval.
newandimproveddonkeykong
Posted - 2 weeks ago
@Quantumup @cash You guys keep posting $UNCY on $ARDX side, so here's what I know about them. Renazorb is an orphan drug bought from spectrum back in 2018. A bioequivalence trial was completed in 2022 and the FDA kicked back the NDA for more data. Fast forward 5 quarters and here we are, waiting for an NDA submission for ANOTHER phosphate binder from $UNCY. Cross posting is part of the game, but come on. UNCY is working on a better VHS recorder two quarters after digital came on the market.
Quantumup
Posted - 2 weeks ago
Piper Sandler🏁 $UNCY OW/$9~says "OLC Is Small But Mighty Just Like This Microcap Name" Views $UNCY trading@cash=sig below its value, but thinks has major upside ahead of OLC approval. Notes CKD=MEGA mkt w/ >500K on kidney dialysis (80%=phosphate binders)=$2.5B WW in '21. $ARDX
Thestocktraderhubzee
Posted - 2 weeks ago
$UNCY Piper Sandler Initiates Coverage On Unicycive Therapeutics with Overweight Rating, Announces Price Target of $9
WagTwits
Posted - 2 weeks ago
$UNCY
TragicTwits
Posted - 2 weeks ago
$UNCY at my average again. Jump in here 🤣 @pocketmoney
BioTekk
Posted - 2 weeks ago
$ARDX Could $UNCY be threat to $ARDX? ? If not, why?
Walter100
Posted - 3 weeks ago
$UNCY
WagTwits
Posted - 3 weeks ago
$UNCY